Rapid Kidney Function Decline in Older Adults
Completed
- Conditions
- Kidney Function DeclineGlomerular Filtration RateUrine Albumin-creatinine RatioHealthy AgingComorbidityChronic Kidney Disease
- Registration Number
- NCT06765811
- Lead Sponsor
- Huashan Hospital
- Brief Summary
This observational study investigates whether a single set of GFR and urine albumin-to-creatinine ratio (ACR) thresholds can accurately screen for rapid kidney function decline in different elderly groups.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1539
Inclusion Criteria
- Age greater than 70 years;
- GFR data measured at least twice (two years apart) and ACR data measured once (at baseline);
- A clear record of the cause of the previous visit; from this, people diagnosed with kidney disease were selected, and kidney disease was defined as various primary nephritis, secondary nephropathy, acute kidney injury (AKI), chronic kidney disease, kidney tumors, or a diagnosis of proteinuria alone.
- Signed informed consent form.
Exclusion Criteria
- People with missing baseline biochemical data;
- Outliers in the population indicators, i.e., data deviating from the mean ± three times the standard deviation;
- Data with significantly abnormal baseline renal function follow-up (abnormally elevated GFR by more than 10% within 2 years or abnormal ACR value as determined by consultation with a senior nephrologist).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A ≥30% decline in glomerular filtration rate (GFR) within 2 years, i.e. a rapid decline in renal function The risk of rapid decline in kidney function in the elderly was assessed during a 2-year follow-up period
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link GFR decline to aging subtypes in NCT06765811 chronic kidney disease study?
How do urine ACR thresholds correlate with biomarkers like KIM-1 or NGAL in rapid kidney function decline?
What adverse events are associated with rapid GFR decline in comorbid elderly populations per NCT06765811?
How does SGLT2 inhibitor use compare to standard CKD management in slowing GFR decline among aging subtypes?
Which geriatric biomarkers predict response to RAAS inhibition in NCT06765811 kidney function decline cohorts?
Trial Locations
- Locations (1)
Huashan hospital, Fudan university
🇨🇳Shanghai, Shanghai, China